Table 2.
The response to TKI therapy | ||||
---|---|---|---|---|
Variables | Patient No. | Unfavorable (%) | Favorable (%) | P |
SHP2 | ||||
Low | 18 | 7 (39) | 11 (61) | 0.044 |
High | 18 | 13 (72) | 5 (28) |
The unfavorable response is defined at least 25% increase in size or number of the tumors; otherwise is defined as a favorable response. The median value of SHP2 mRNA levels was used as cutoff point to divide patients into “high” and “low” subgroups.